Pfizer

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Pfizer 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About PFE

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. 

CEO
Albert Bourla
CEOAlbert Bourla
Employees
75,000
Employees75,000
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
1849
Founded1849
Employees
75,000
Employees75,000

PFE Key Statistics

Market cap
159.96B
Market cap159.96B
Price-Earnings ratio
37.17
Price-Earnings ratio37.17
Dividend yield
6.13%
Dividend yield6.13%
Average volume
36.90M
Average volume36.90M
High today
$28.43
High today$28.43
Low today
$27.66
Low today$27.66
Open price
$27.78
Open price$27.78
Volume
37.11M
Volume37.11M
52 Week high
$28.75
52 Week high$28.75
52 Week low
$23.58
52 Week low$23.58

Stock Snapshot

The current Pfizer(PFE) stock price is $28.08, with a market capitalization of 159.96B. The stock trades at a price-to-earnings (P/E) ratio of 37.17 and offers a dividend yield of 6.13%.

On 2026-08-22, Pfizer(PFE) stock traded between a low of $27.66 and a high of $28.43. Shares are currently priced at $28.08, which is +1.5% above the low and -1.2% below the high.

The Pfizer(PFE)'s current trading volume is 37.11M, compared to an average daily volume of 36.9M.

During the past year, Pfizer(PFE) stock moved between $23.58 at its lowest and $28.75 at its peak.

During the past year, Pfizer(PFE) stock moved between $23.58 at its lowest and $28.75 at its peak.

PFE News

TipRanks 2h
Pfizer’s Quiet Trial Wave Hints at Big Pipeline Upside

Pfizer ( (PFE) ) has been popular among investors this week. Here is a recap of the key news on this stock. Summer Sale - Claim 70% Off TipRanks Unlock powerful...

The Motley Fool 3h
Prediction: This Is Where Pfizer Stock Will Be in 2030

Pfizer (PFE +1.01%) has an attractive 6.4% dividend yield. That compares to 1% for the S&P 500 index (^GSPC +0.43%) and 1.4% for the average pharmaceutical stoc...

Prediction: This Is Where Pfizer Stock Will Be in 2030
Simply Wall St 8h
Is The Depo-Provera Meningioma Settlement Reshaping Legal Risk In Pfizer’s Investment Case?

In August 2026, Legal Bay LLC announced that Pfizer and plaintiffs' leadership had agreed to a Depo-Provera settlement program intended to resolve a large porti...

Is The Depo-Provera Meningioma Settlement Reshaping Legal Risk In Pfizer’s Investment Case?

Analyst ratings

62%

of 29 ratings
Buy
31%
Hold
62.1%
Sell
6.9%

More PFE News

TipRanks 1d
Pfizer Advances PF-07248144 With Key Drug-Interaction Study Completion

Pfizer Inc (PFE) announced an update on their ongoing clinical study. Unlock powerful investing tools with TipRanks Premium to make smarter, more confident inv...

TipRanks 1d
Pfizer’s Atirmociclib Study Marks Quiet but Important Step in Pipeline Progress

Pfizer Inc (PFE) announced an update on their ongoing clinical study. Unlock powerful investing tools with TipRanks Premium to make smarter, more confident inv...

The Motley Fool 2d
The Dividend ETF That Generates Passive Income While You Sleep

Exchange-traded funds (ETFs) can serve as a valuable investment vehicle for risk-averse investors who are seeking income but are worried about the price swings...

The Dividend ETF That Generates Passive Income While You Sleep
Simply Wall St 2d
Pfizer Rides MRNA Cancer Optimism On A Valuation That Still Looks Modest

Pfizer (PFE) moved back onto investor watchlists after Merck and Moderna reported positive Phase 3 results for an mRNA melanoma treatment, lifting sentiment tow...

Pfizer Rides MRNA Cancer Optimism On A Valuation That Still Looks Modest
24/7 Wall St. 2d
Dividend Giants Pfizer, Chevron, AbbVie: Bold 2027 Price Targets Ahead

The most widely read finance newsletter on Substack isn't published by a bank, it's Doomberg , where 383,000+ readers get the energy and macro analysis the main...

Dividend Giants Pfizer, Chevron, AbbVie: Bold 2027 Price Targets Ahead
TipRanks 2d
Pfizer’s Ibrance Real-World Breast Cancer Study Wraps Up: What Investors Should Watch Next

Pfizer Inc (PFE) announced an update on their ongoing clinical study. Unlock powerful investing tools with TipRanks Premium to make smarter, more confident inv...

24/7 Wall St. 2d
Yield Hunters Are Swarming This 6.3%-Dividend Stock—And Big-League Hedge Funds are Quietly Buying the Dip

Yield Hunters Are Swarming This 6.3%-Dividend Stock—And Big-League Hedge Funds are Quietly Buying the Dip By Joey Frenette Published Aug 20, 11:34AM EDT Quick...

Yield Hunters Are Swarming This 6.3%-Dividend Stock—And Big-League Hedge Funds are Quietly Buying the Dip

People also own

Based on the portfolios of people who own PFE. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.